Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Behav Brain Res. 2011 Mar 1;217(2):399–407. doi: 10.1016/j.bbr.2010.11.018

Figure 5. SL327 did not alter expression of EtOH-CPP following both 2- and 4-trial conditioning.

Figure 5

(A) SL327 (50 mg/kg), when administered prior to the CPP test did not alter expression of EtOH-CPP but did significantly reduce test activity (inset). (B) SL327 also failed to alter expression of EtOH-CPP following an extended conditioning (4-trials) procedure. As in 5A, SL327 significantly reduced test activity (inset). Error bars indicate standard error of the mean.

* denotes a significant decrease in activity as compared to the Vehicle-treated group (p < .05).